BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26620948)

  • 1. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital.
    Morfin-Otero R; Garza-Gonzalez E; Aguirre-Diaz SA; Escobedo-Sanchez R; Esparza-Ahumada S; Perez-Gomez HR; Petersen-Morfin S; Gonzalez-Diaz E; Martinez-Melendez A; Rodriguez-Noriega E;
    Braz J Infect Dis; 2016; 20(1):8-13. PubMed ID: 26620948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
    Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
    Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAP1 strain type predicts outcomes from Clostridium difficile infection.
    See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
    Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection in children hospitalized due to diarrhea.
    Dulęba K; Pawłowska M; Wietlicka-Piszcz M
    Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):201-9. PubMed ID: 24213847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
    Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
    Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
    Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
    J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
    Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
    Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued decline in the prevalence of the Clostridioides difficile BI/NAP1/027 strain across the United States Veterans Health Administration.
    Gentry CA; Williams RJ; Campbell D
    Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115308. PubMed ID: 33626478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.
    Dantes R; Epson EE; Dominguez SR; Dolan S; Wang F; Hurst A; Parker SK; Johnston H; West K; Anderson L; Rasheed JK; Moulton-Meissner H; Noble-Wang J; Limbago B; Dowell E; Hilden JM; Guh A; Pollack LA; Gould CV
    Am J Infect Control; 2016 Feb; 44(2):138-45. PubMed ID: 26601705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of strain typing results for Clostridium difficile isolates from North America.
    Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
    J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains.
    Stoesser N; Eyre DW; Quan TP; Godwin H; Pill G; Mbuvi E; Vaughan A; Griffiths D; Martin J; Fawley W; Dingle KE; Oakley S; Wanelik K; Finney JM; Kachrimanidou M; Moore CE; Gorbach S; Riley TV; Crook DW; Peto TEA; Wilcox MH; Walker AS;
    PLoS One; 2017; 12(8):e0182307. PubMed ID: 28813461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection: Description of NAP1/027 and non NAP1/027 strains in a high complexity center in Cali, Colombia, 2012-2015.
    Oñate-Gutiérrez JM; Segura J; Correa A; Cantor E; Villegas MV
    Biomedica; 2019 May; 39(s1):63-70. PubMed ID: 31529849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
    Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridioides difficile-associated diarrhea in surgical service patients in Mexico.
    Morfín-Otero R; Petersen-Morfín S; Aguirre-Díaz SA; Pérez-Gómez HR; Garza-González E; González-Díaz E; Esparza-Ahumada S; Velarde-Ruiz Velasco JA; León-Garnica G; Escobedo-Sánchez R; Rodríguez-Noriega E
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(3):227-234. PubMed ID: 31416629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving epidemiology of
    Katz KC; Golding GR; Choi KB; Pelude L; Amaratunga KR; Taljaard M; Alexandre S; Collet JC; Davis I; Du T; Evans GA; Frenette C; Gravel D; Hota S; Kibsey P; Langley JM; Lee BE; Lemieux C; Longtin Y; Mertz D; Mieusement LMD; Minion J; Moore DL; Mulvey MR; Richardson S; Science M; Simor AE; Stagg P; Suh KN; Taylor G; Wong A; Thampi N;
    CMAJ; 2018 Jun; 190(25):E758-E765. PubMed ID: 29941432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
    Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
    Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribotype variability of Clostridioides difficile strains in patients with hospital-acquired C. difficile infections, community-acquired C. difficile infections, and colonization with toxigenic and non-toxigenic strains of C. difficile.
    Kim B; Seo MR; Kim J; Pai H
    Anaerobe; 2019 Dec; 60():102086. PubMed ID: 31404682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.